Market Overview The US Medical Foods Market is experiencing explosive growth driven by FDA regulatory clarity, metabolic disorder prevalence, and specialized formulation innovation. The market was valued at USD 24.05 billion in 2024 and is projected to grow from USD 25.57 billion in 2025 to USD 47.19 billion by 2035 at a 6.32% CAGR. Phenylketonuria and inborn errors of metabolism represent...